The report “Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) – Global Forecast to 2027”, is expected to reach USD 13.89 billion by 2027 from USD 5.32 billion in 2017, at a CAGR of 10.2%.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773



Services segment is expected to grow at the highest CAGR during the forecast period.



Based on service and product, the drug screening market is segmented into services and products. The services segment accounted for the largest share of 57.4% of the drug screening market in 2020. This segment is also expected to register the highest CAGR during the forecast period, mainly due to the growing drug alcohol consumption worldwide, funding initiatives for drug testing laboratories, service launches and regulatory approvals, and geographic expansion of drug testing laboratories.

Analytical instruments are expected to dominate the drug screening products market in 2020.

Based on the product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. In 2020, the analytical segment is expected to dominate the market with a share of 53.0%. The high growth in this segment is owing to their recurring requirement and repetitive usage.

Browse and in-depth TOC on “Drug Screening Market”

204 – Tables

42 – Figures

203 – Pages

Read More in Detailed (Drug screening Market ): https://www.marketsandmarkets.com/PressReleases/drug-alcohol-screen...

Based on the sample type, the urine sample segment is accounted for the largest share of the drug screening market.

By sample type, drug screening market is segmented into urine, breath, oral fluid, hair, and other samples. Among these, the urine sample segment is expected to account for the largest share of 61.5% in 2020. The high growth of this segment is attributed due to the benefits it offers such as easy collection method, high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.

North America to dominate the drug screening market in 2020.

In 2020, North America is expected to dominate the market with a share of 48.2%, followed by Europe. The large share of this geographical segment is attributed to factors such as growing consumption of illicit drugs, the availability of government funding to curb drug abuse, laws supporting drug screening, the growing burden of accidents due to alcohol impairment, and the presence of key players in the region are driving the growth of the drug screening market in this region.